Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166230 · ClinicalTrials.gov registry record
Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB
A clinical trial, sponsored by Photocure.
- Completed
- Registry status
- 551
- Enrollment target
NCT01166230 is a clinical trial that has completed, run by Photocure. The registered enrollment target is 551 participants.
The verdict
NCT01166230 has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- 551 participants
- Enrollment target
Study Summary
The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will lead to a longer-term reduction in recurrences compared to standard white light cystoscopy/TURB.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166230
The ClinicalTrials.gov registry entry for NCT01166230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01166230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01166230 about?
NCT01166230 is a clinical study titled "Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB". The study is intended to investigate whether the improved initial detection and resection of bladder cancer lesions in patients with non-muscle invasive bladder cancer with Hexvix (Cysview) fluorescence cystoscopy/TURB will lead to a longer-term reduction in recurrences compared to standard white li...
What is the current status of trial NCT01166230?
This trial is currently completed. The enrollment target is 551 participants. The study started on 2010-06. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01166230?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.